carbachol has been researched along with Osteoarthritis in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Osteoarthritis: A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, HL | 1 |
| Ranasinghe, CL | 1 |
1 trial available for carbachol and Osteoarthritis
| Article | Year |
|---|---|
"G.T. 50" in the treatment of osteoarthritis; a preliminary evaluation.
Topics: Carbachol; Clinical Trials as Topic; Humans; Neostigmine; Osteoarthritis; Vitamin D | 1965 |